Related Topics News -

     
 Title only   |   Print    Next page > 
     
《業績》樂普生物全年虧轉盈賺2.61億人幣 首年實現盈利

2026-03-25T  
樂普生物:AstraZeneca完成CMG901首例受試者試藥

2026-03-11T  
樂普生物料去年虧轉盈 賺至少2億元人幣

2026-03-11T  
樂普生物注射用維貝柯妥塔單抗在中國獲批上市

2025-10-30T  
《業績》樂普生物半年虧轉盈賺4,174.5萬人幣

2025-08-20T  
《盈喜》樂普生物料上半年虧轉盈 賺不少於2,400萬人幣

2025-08-06T  
《港股》恆指半日跌148點 友邦挫跌4%成交額逾291億 阿里健康挫6%

2025-07-04T  
《大行》交銀國際列出南向資金對港股各行業持倉分佈及配置集中度(表)

2025-07-04T  
《大行》交銀國際:南向資金近月主力配置集中醫療和金融板塊 反映對高息防禦價值重視

2025-07-04T  
樂普生物折讓近11%配售H股 淨籌逾4.6億元

2025-07-04T  
  Next page > 

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2026 Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.